Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-054973
Filing Date
2022-11-01
Accepted
2022-11-01 11:08:38
Documents
2
Period of Report
2022-06-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3847
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 6896
  Complete submission text file 0001209191-22-054973.txt   12083
Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Issuer) CIK: 0001633932 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1226 CHARTER LANE AMBLER PA 19002
Business Address
Thorell Marella (Reporting) CIK: 0001826323 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37410 | Film No.: 221348998